医药前沿
醫藥前沿
의약전연
YIAYAO QIANYAN
2015年
22期
24-24,25
,共2页
老年内科%肾衰竭%血液透析%感染%防范
老年內科%腎衰竭%血液透析%感染%防範
노년내과%신쇠갈%혈액투석%감염%방범
Elderly medical%Kidney failure%Hemodialysis%Infection%To guard against
目的：分析老年慢性肾衰竭患者行维持性血透的临床特点，探讨提高老年血透患者生活质量和生存率的方法。方法：收集57例65岁以上的老年血透患者(观察组)和50例非老年血透患者(对照组)的临床资料。结果：观察组患者治疗前后血尿素(BUN)、肌酐(Cr)比较差异有统计学意义(P<0.05)，组间比较差异无统计学意义(P>0.05)；两组BUN清除率、肌酐清除率(Ccr)比较差异无统计学意义(P>0.05)；观察组患者血透后存活时间少于对照组(P<0.05)，血透过程中低血压、高血压、心律失常及心绞痛发生次数明显多于对照组(P<0.05)。结论：老年慢性肾衰竭维持性血液透析治疗时容易出现心血管并发症及感染因素，血透中必须密切观察患者的心血管疾病发生，并及时处理，以提高患者的生活质量和生存率。
目的：分析老年慢性腎衰竭患者行維持性血透的臨床特點，探討提高老年血透患者生活質量和生存率的方法。方法：收集57例65歲以上的老年血透患者(觀察組)和50例非老年血透患者(對照組)的臨床資料。結果：觀察組患者治療前後血尿素(BUN)、肌酐(Cr)比較差異有統計學意義(P<0.05)，組間比較差異無統計學意義(P>0.05)；兩組BUN清除率、肌酐清除率(Ccr)比較差異無統計學意義(P>0.05)；觀察組患者血透後存活時間少于對照組(P<0.05)，血透過程中低血壓、高血壓、心律失常及心絞痛髮生次數明顯多于對照組(P<0.05)。結論：老年慢性腎衰竭維持性血液透析治療時容易齣現心血管併髮癥及感染因素，血透中必鬚密切觀察患者的心血管疾病髮生，併及時處理，以提高患者的生活質量和生存率。
목적：분석노년만성신쇠갈환자행유지성혈투적림상특점，탐토제고노년혈투환자생활질량화생존솔적방법。방법：수집57례65세이상적노년혈투환자(관찰조)화50례비노년혈투환자(대조조)적림상자료。결과：관찰조환자치료전후혈뇨소(BUN)、기항(Cr)비교차이유통계학의의(P<0.05)，조간비교차이무통계학의의(P>0.05)；량조BUN청제솔、기항청제솔(Ccr)비교차이무통계학의의(P>0.05)；관찰조환자혈투후존활시간소우대조조(P<0.05)，혈투과정중저혈압、고혈압、심률실상급심교통발생차수명현다우대조조(P<0.05)。결론：노년만성신쇠갈유지성혈액투석치료시용역출현심혈관병발증급감염인소，혈투중필수밀절관찰환자적심혈관질병발생，병급시처리，이제고환자적생활질량화생존솔。
Objective To analyze the clinical characteristics of elderly line maintenance hemodialysis patients with chronic renal failure, and explore the method of raising the life quality and survival rate of elderly hemodialysis patients. Methods To collect 65 elderly hemodialysis patients over the age of 57 cases (observation group) and 50 cases of the clinical data of elderly hemodialysis patients (control group). Results The observation group of patients before and after treatment the blood urea (BUN), creatinine (Cr), compare the difference was statistically significant (P<0.05), and compare the differences between groups have no statistical significance (P>0.05);Clearance of two groups of BUN and creatinine clearance rate (Ccr) compare the differences had no statistical significance (P>0.05);Observation group after hemodialysis patients survival time less than the control group (P<0.05), low blood pressure, high blood pressure, cardiac arrhythmia during the process of hemodialysis and angina occurred significantly more than the control group (P<0.05). Conclusion The chronic renal failure maintenance hemodialysis treatment of cardiovascular complications and easy to appear when infection factors, must be closely observed in hemodialysis patients with cardiovascular disease, and timely treatment, in order to improve the patient's quality of life and survival rate.
